There are many alternative
treatment options that could benefit mesothelioma patients. Some of the leading alternative
treatments include:
Cachexia Treatments
Cachexia is a condition that involves the loss of weight and muscles, something
that can be detrimental and debilitating to the mesothelioma patient.
Cachexia treatments aim to give people more muscle strength in their fight
against cancer.
Palliative Care
Many physicians believe palliative care should be a priority for mesothelioma
patients. Cancer patients can perceive pain not only from the disease
itself, but from the treatments. Palliative care, in a nutshell, involves
pain management tactics to alleviate the
symptoms of mesothelioma and treatments such as
chemotherapy.
High Dose of Ascorbic Acid
Some physicians opt to treat their patients by intravenously administering
high doses of ascorbic acid for the purpose of slowing down the rate that
mesothelioma tumors grow.
Oncolyn
Oncolyn is a natural, plant-derived substance that may be effective in
the treatment of mesothelioma.
Estrogen Treatment
Researchers have found that the more estrogen a mesothelioma cell contains,
the less the cancer grows and spreads, which might explain why women often
have less aggressive tumors and survive longer with mesothelioma than men.
Photodynamic Therapy
One of the more innovative treatments for malignant pleural mesothelioma
is photodynamic therapy of “PDT.” The procedure works by eradicating
residual microscopic disease after macroscopic complete resection of mesothelioma.
In Vitro Tree Oil
A study has suggested that in vitro implantation of tree oil may be effective
in killing mesothelioma cells. Research has shown that the anti-fungal
and antibiotic properties in tree oil can effectively kill cancerous cells.
One of the major benefits of working with asbestos lawyers at Worthington
& Caron, PC is our connection to the nation’s foremost meso
physicians and treatments. If you would like to learn more about how we
could help you after a mesothelioma
diagnosis, call today.